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Abstract 
Australia’s aging population has heightened demand for earlier detection and prevention 
methods for dementia. Studies have shown that autonomic dysfunction precedes mild 
cognitive impairment, a precursor to dementia (Collins et al., 2012). The present study 
explores the links between heart rate variability (HRV) (reflecting autonomic activity), 
blood pressure (BP), and cognitive function in non-clinical and clinical cohorts 
(depression, diabetes (type 1 and 2), and hypertension).  
Participants were added to an existing database (De Leon, 2009, Smith, 2010) (n=100) to 
produce a cumulative sample of n=297. The experimental protocol commenced with three 
baseline BP measurements, the Lifestyle Appraisal Questionnaire (Craig et al., 1996) and 
the Disease State Questionnaire (Giblin, 2013). The participant underwent two 
electrocardiogram recordings for HRV analysis (10 minutes of baseline and 10 minutes 
of a cognitive task). Two psychometric tests were then administered: the Mini-Mental 
State Examination (Folstein et al., 1975) and the Cognistat (Kiernan et al., 1987). Finally, 
three additional BP measurements completed the study protocol. 
Higher baseline parasympathetic activity was significantly correlated (p=<0.05) to better 
cognitive performance (e.g. memory) in females 18-50 years and males 51-65 years 
however this was also correlated to poorer cognitive scores (e.g. judgment) in females 
36-65 years and males 36-50 years. HRV reactivity (cognitive task minus baseline) was 
mostly positively correlated to cognition (e.g. comprehension) in females 18-35 and 51-
65 years. 
Higher vagal activity was linked to higher cognitive scores (e.g. attention) in all clinical 
groups yet also linked to poorer cognitive scores (e.g. orientation) in the type 1 diabetes 
and hypertension groups. HRV reactivity was mostly positively correlated to cognition 
(e.g. naming) in the hypertension sample yet inversely linked to cognition in the other 
clinical groups. 
Both clinical and non-clinical groups had positive correlations between BP reactivity and 
cognitive performance (e.g. attention), suggesting low BP reactivity may be a predictor 
for cognitive decline.  
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These initial findings contribute new knowledge to the field of HRV and cognition, 
particularly in clinical groups and the less-studied HRV and BP reactivity in clinical and 
non-clinical groups. By gaining a better understanding of early autonomic risk factors for 
cognitive impairment, preventative countermeasures (e.g. anti-hypertensive use and 
autonomic biofeedback) may be considered to slow or cease dementia progression. 
Delaying or stopping the development of dementia has the potential to reduce expected 
rises in government expenditure, lower the burden on carers and nursing homes, lengthen 
lifespans, and ultimately improve the quality of life in elderly populations. 
 
 
 
